Company: INMB
Filing Date: 2025-03-07
Form Type: 424B5
Source: 0001213900-25-021719
Chunk: 19

Company: Inmune Bio, Inc.
Filing Date: 2025-03-07
Form: 424B5
Chunk 19
---
 purchase shares of common stock offered hereby and is subject
in all respects to the provisions contained in the Warrants. Except as otherwise provided in the Warrants or by virtue of such holder’s
ownership of shares of our common stock, the holders of the Warrants will not have the rights or privileges of a holder of our common
stock, including any voting rights, until the holder exercises the Warrants.

April 2024 Warrants

Duration and Exercise Price

Each April 2024 Warrant has an initial exercise
price of $9.152 per share. The April 2024 Warrants were immediately exercisable upon issuance on April 24, 2024 (the “April Initial
Exercise Date”) and expire on the later of (i) April 24, 2026 or (ii) thirty (30) trading days following the public announcement
by us reporting top line data (EMACC) in our Phase 2 Alzheimer’s program of XPRO1595. The exercise price and number of shares of
common stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations
or similar events affecting our common stock and the exercise price. Each April 2024 Warrant is exercisable for one share of common stock.

Exercisability

The April 2024 Warrants are exercisable, at the
option of each holder, in whole or in part, by delivering a duly executed exercise notice accompanied by payment in full for the number
of purchased upon such exercise (except in the case of a cashless exercise). A holder (together with its affiliates) may not exercise
any portion of the April 2024 Warrant to the extent that the holder would own more than 4.99% (or, at the election of a purchaser, 9.99%)
of the outstanding common stock immediately after exercise, except that upon at least 61 days’ prior notice from the holder to us,
the holder may increase the amount of ownership of outstanding common stock after exercising the holder’s April 2024 Warrants up
to 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise, as such percentage ownership
is determined in accordance with the terms of the April 2024 Warrants. No fractional shares of common stock will be issued in connection
with the exercise of the April 2024 Warrants. In lieu of fractional shares, we will pay the holder an amount in cash